(Q33356816)

26 July 2017

title

Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial (English)

1 reference

26 July 2017

0 references

1 reference

1 reference

Elaine Beller

4

0 references

Paolo Ferrari

Paolo Ferrari

7

0 references

Carmel Hawley

Carmel Mary Hawley

2

0 references

David Johnson

David Wayne Johnson

1

0 references

Alan Cass

10

Alan Cass

1 reference

26 July 2017

Brenda Rosser

3

1 reference

26 July 2017

Charles Thompson

5

1 reference

26 July 2017

Robert G Fassett

6

1 reference

26 July 2017

Stephen MacDonald

8

1 reference

26 July 2017

Eugenie Pedagogos

9

1 reference

26 July 2017

publication date

1 August 2008

1 reference

26 July 2017

1 reference

26 July 2017

volume

9

1 reference

26 July 2017

page(s)

8

1 reference

Creative Commons Attribution 2.0 Generic

26 July 2017

copyright license

start time

1 August 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Regulation of hepcidin transcription by interleukin-1 and interleukin-6.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Pentoxifylline diminished acetaldehyde-induced collagen production in hepatic stellate cells by decreasing interleukin-6 expression.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Hepcidin, a urinary antimicrobial peptide synthesized in the liver

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Effects of pentoxifylline on the haematologic status in anaemic patients with advanced renal failure

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Strategies for iron supplementation: oral versus intravenous

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Plasma levels of TNF and IL-6 following induction of acute pancreatitis and pentoxifylline treatment in rats.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Anemia in hemodialysis patients: variables affecting this outcome predictor.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Erythropoietin in chronic renal failure

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Production of proinflammatory cytokines and cytokines involved in the TH1/TH2 balance is modulated by pentoxifylline

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Effect of pentoxifylline on apoptosis of cultured cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2519060

A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study).

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-9-8

Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-9-8

Pentoxifylline improves hemoglobin levels in patients with erythropoietin-resistant anemia in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-9-8

Associations between circulating inflammatory markers and residual renal function in CRF patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-9-8

Prohepcidin accumulates in renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-9-8

Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity

21 January 2018

1 reference

12 December 2020

Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells

1 reference

12 December 2020

Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients

1 reference

12 December 2020

Pentoxifylline. A hydroxyl radical scavenger

1 reference

12 December 2020

Regulatory effects of pentoxifylline on T-helper cell-derived cytokine production in human blood cells

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2369-9-8

1 reference

Dimensions Publication ID

26 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2369-9-8

9 September 2019

1 reference

26 July 2017

1 reference